Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 12
Original Research
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,061 | Dovepress* | 14,228+ | 1,453 | 15,681 | |
| PubMed Central* | 2,833 | 573 | 3,406 | ||
| Totals | 17,061 | 2,026 | 19,087 | ||
| *Since 11 November 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 0 | 0 | 0 | 3 | 5 |
View citations on PubMed Central and Google Scholar